Pluri Inc. Reports $5.9 Million Loss in Fiscal Q1 2023

Pluri Inc., a biotechnology company based in Haifa, Israel, announced its fiscal first-quarter financial results, revealing a net loss of $5.9 million. This translates to a loss of $1.08 per share. During the same period, the company reported revenue amounting to $326,000. These figures provide insight into the company's current financial health and operational performance.